A new study, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, integrates patient funding programs for pharmacist teams to dramatically improve access to pharmaceutical company funding for uninsured and vulnerable cancer patients.

With the breakthrough of medical technology, various new therapies, precision medicine and medical materials have been introduced, and people have more choices, but they also face a great financial burden. We have long supported the Smart Patient Leadership Academy, which aims to cultivate patient leaders, and provides corporate volunteers, strategic consultants, resource matching and other services. With such support, the Smart Patient Leadership Academy invited experts from all walks of life to share the topic of “The Feasibility of Synergizing Health Insurance with Commercial Insurance” on 8/7, during which they discussed the current situation of health insurance and commercial insurance in Taiwan, and analyzed the current plans of other countries as a reference for future policies.